Vesper bats, a family of more than 500 species found on every continent except Antarctica, carry two complete sets of the genes that build antibody heavy chains. Every other mammal examined closely has one. The arrangement was reported in a study in Science Advances by a team from Tulane University working with Stanford University and the Centers for Disease Control and Prevention, and it has a consequence that reaches past evolutionary biology: the blood tests used to estimate how many bats have been exposed to a virus may not be capturing the full antibody response.

That is the practical edge of this story, and it comes from the authors themselves, who note that previous serological studies of infection or vaccination in bats may have overlooked aspects of the bat antibody response. Serology, the analysis of antibodies in blood, is the standard tool for tracking viral prevalence in bat populations worldwide, and the reagents behind those tests were designed around the single antibody locus found in humans and laboratory mice.

For state wildlife agencies, university field crews and tribal natural resource departments running bat surveillance across the United States, that is a measurement question with budget and policy implications. It does not mean past surveys were wrong. It means the confidence attached to them deserves rechecking.

Two Loci, Different Jobs, One Ancient Duplication

Antibodies are Y-shaped proteins built from two heavy chains and two light chains. In humans and every other known mammal, a single gene cluster produces the heavy chains. The researchers annotated immunoglobulin loci across vespertilionid bats and identified dual, functional heavy-chain loci on separate chromosomes in 26 species.

The two are not interchangeable. In the big brown bat, Eptesicus fuscus, the common North American species used for the detailed work and a main rabies reservoir, the smaller locus spans roughly 272 kilobases on one chromosome while the larger spans about 918 kilobases on another. Single-cell transcriptome studies of B cells and plasma cells confirmed that both rearrange and are expressed, that normal allelic exclusion is maintained, that usage is biased toward the smaller and more compact locus, and that antigen-experienced B cells and plasma cells show different patterns of selection depending on which locus they use. The blueprint looks reorganized rather than simply doubled.

"We've never seen anything like this in a mammal before," said Hannah Frank, associate professor of ecology and evolutionary biology at Tulane and corresponding author, in a statement from Tulane University. "This completely changes our understanding of how mammalian immune systems can be organized and raises exciting new questions about why bats have been so evolutionarily successful and how they respond to viruses."

The pattern across the family points to a duplication in a shared ancestor. The authors note that the only comparable arrangement known in vertebrates is the more limited duplication seen in teleost fish.

What It Explains, and What It Does Not

This is where the reporting has to slow down. The study did not infect any bats. There was no comparison showing that bats with two loci fare better than bats with one, and no experiment removing either locus. The authors' language reflects that the arrangement may contribute to bat resistance to viral pathogenesis. It is a hypothesis about mechanism, not a demonstrated cause of viral tolerance.

Frank was direct about the limits. "It doesn't fully explain why bats are such effective viral reservoirs, but it reveals a level of immune variety we didn't know existed and gives us an entirely new direction to explore," she said.

An independent researcher not involved in the work agreed on the significance while framing it as an opening. "The study provides a novel view into the evolution and diversity of adaptive immunity in bats," said Daniel Becker, an associate professor of biology at the University of Oklahoma, in comments to Live Science. "The duplication seen in vesper bats is really intriguing and suggests that we need more immunological study of this globally distributed family of bats."

Most bat immunology has concentrated on innate immunity, the fast general-purpose defenses. This study argues the adaptive side, the antibody-producing machinery, has been understudied.

A Second Line of Evidence From a Different Team

Nature World News previously reported on separate research linking bat genomes to both virus defense and long life as white-nose syndrome thins Myotis colonies. That work, published in Nature by a group led from the University of California, Berkeley, generated near-complete genome assemblies and cell lines for eight closely related Myotis species and found distinctive modes of adaptation to viruses, including Myotis-specific duplications of the key antiviral gene PKR.

The two studies come from different teams using different methods, and they converge on gene duplication and immune function as central to bat biology. The Berkeley group also found that cells from the little brown bat, Myotis lucifugus, the longest-lived species in its sample, responded to severe chemical damage by ramping up genes that trigger cell death rather than DNA repair.

"We found the literal opposite of what we expected if you treat the bats with a lethal dose of this chemical," said Juan Manuel Vazquez, who co-led that study and is now at Pennsylvania State University, in a Berkeley News account of the bat genome work. "The longest-lived bat in North America decides 'I can't save this ship' and immediately switches gears to prioritize killing off the cells that are damaged."

Taken together, the picture is of animals that tolerate viruses and resist cancer through several reinforcing adaptations rather than one trick. Neither study makes bats more dangerous or less dangerous than they were last month.

Nothing Here Changes What Homeowners Should Do

Public health guidance is unchanged. Anyone who finds a bat inside a living space, or who has direct contact with one, should contact their local health department, because rabies risk assessment is a matter for medical professionals and the CDC's guidance on bats has not been revised by this research. People who find bats roosting in a structure should contact their state wildlife agency rather than handling the animals, since several Myotis species are federally protected or under status review.

None of this justifies culling. Bats are pollinators, seed dispersers and significant agricultural pest controllers, and the same family at the center of this study has been hit hard by white-nose syndrome, with cumulative mortality estimated in the millions since the disease was first identified in New York in the winter of 2006 to 2007. Frank framed the opportunity as a matter of looking beyond the usual model species. "We've learned an enormous amount about immunity by studying humans and laboratory mice," she said. "But the natural world is far more varied than that."

The open questions are substantial. Whether the duplication actually improves survival during infection has not been tested. Whether serological surveys systematically undercount exposure has not been quantified. Whether the finding leads anywhere in human immunology is years from being answerable. What comes next is laboratory work on antibody reagents that can capture both systems, and that is the development worth watching, because it determines whether wildlife disease monitoring needs recalibrating.

What Readers Want to Know

What did researchers find? That vesper bats carry two complete, functional sets of antibody heavy-chain genes on separate chromosomes, an arrangement not previously documented in any mammal.

How many species have it? Dual heavy-chain loci were identified in 26 vespertilionid species, a family that includes more than 500 species worldwide.

Does this prove why bats do not get sick from viruses? No. There was no infection experiment. The researchers describe it as a possible contributing factor, not a demonstrated cause.

Could this affect bat disease surveillance? Possibly. The authors note that earlier serological studies may have missed aspects of the bat antibody response, because standard tests were built around the single-locus mammal template. The size of any undercount has not been measured.

Does this change what I should do if a bat gets into my house? No. Contact your local health department for any direct contact, and your state wildlife agency for roosting bats. Do not handle the animal.

Are bats more dangerous because of this? No. The finding describes how bats may tolerate viruses. It does not change transmission risk or existing public health guidance.

Why does bat conservation still matter here? White-nose syndrome has killed millions of North American bats, and several Myotis species are protected or under federal status review while providing substantial pest-control value.